Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to assess immunogenicity for future vaccines to ensure that people who are immunosuppressed are protected against vaccine-preventable diseases.

Immunogenicity for future vaccines cannot be assessed until vaccines are tested in clinical trials. All vaccines must first be assessed for safety by the Medicines and Healthcare products Regulatory Agency. It is the responsibility of vaccine manufacturers to include immunosuppressed individuals and assess immunogenicity in clinical trials.